This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Thimble Point Acquisition, Pear Therapeutics Close SPAC Merger; Combined Firm to Begin Trading Monday MT
Thimble Point Acquisition Corp.(NasdaqCM:THMA) dropped from NASDAQ Composite Index CI
Pear Therapeutics, Inc. completed the acquisition of Thimble Point Acquisition Corp. from LJ10 LLC and others in a reverse merger transaction. CI
Pear Therapeutics Receives FDA Breakthrough Designation for reSET-A DJ
Thimble Point Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Certain Class B Common Stock of Thimble Point Acquisition Corp. are subject to a Lock-Up Agreement Ending on 2-AUG-2021. CI
Thimble Point Acquisition : Pear Therapeutics to Merge With Thimble Point Acquisition to Go Public, Strengthen Position in Prescription Digital Therapeutics MT
Thimble Point Acquisition : Pear Therapeutics to Go Public by Combining with Blank-Check Firm Thimble Point Acquisition in $1.6 Billion Deal MT
Pear Therapeutics, Inc. entered into a definitive business combination agreement to acquire Thimble Point Acquisition Corp. from LJ10 LLC and others in a reverse merger transaction. CI
Thimble Point Acquisition Corp.(NasdaqCM:THMA) added to NASDAQ Composite Index CI
Thimble Point Acquisition Corp. Announces Board Appointments CI
Thimble Point Acquisition Corp. announced that it has received $7.52 million in funding from Lj10 Llc CI
Thimble Point Acquisition Corp. has completed an IPO in the amount of $240 million. CI
Thimble Point Acquisition Corp. has filed an IPO in the amount of $200 million. CI
Thimble Point Acquisition Corp. announced that it expects to receive $6 million in funding from Lj10 Llc CI
Chart THIE POIN
More charts
Thimble Point Acquisition Corp. is a blank check company. The Company created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses on software and technology-enabled sectors. The Company has no operations and has not generated revenues.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. THMA Stock
  4. News THIE POIN
  5. Thimble Point Acquisition : Pear Therapeutics to Go Public by Combining with Blank-Check Firm Thimble Point Acquisition in $1.6 Billion Deal